Background: Schizophrenia is a brain disorder which affects the way a person acts, thinks, and sees the world and causes difficulties in socializing with others creates a feeling of inability or inadequacy. Social support has an impact on mental and physical health throughout the life span. Lower social support has been associated with poor treatment outcomes. Poor social function has been found to increase admission rates.but in this study setting there is no evidence which shows the level of perceived social support and associated factors among people with schizophrenia. Objective: The aim of this study is to assess Level of perceived social support and associated factors among peoples with Schizophrenia at Amanuel mental specialized hospital, Addis Ababa, 2017. Method: An institutional based cross sectional study was conducted from May-to June-2017. Systematic random sampling technique was used to select study participants. Structured questionnaire with systematic random sampling approach followed by face to face interview technique were used. Epic-info version 7 and SPSS version 20 software were used for data entry and analysis respectively. Descriptive statistics were employed to describe the data. Data were fitted with bivariate and multivariate Ordinal logistic regression. Statistical significance were declared 95% confidence interval and P value <0.05. Results: A total of 410 study participants were participated. The study showed that; low perceived social support, medium perceived social support and high perceived social support account for 21.5%, 58.5% and 20% respectively. Poor medication adherence (AOR=3.61(95% CI; 2.10, 6.18), greater than 3 hospital admission (AOR=0.46(95% CI; 0.27, 0.79), primary (AOR=0.45(95%CI; 0.24, 0.82) and secondary level of education (AOR=0.53(95%CI; 0.31, 0.91) were found to be statistically significant associated with the outcome. Conclusion and Recommendation: This study showed that people with schizophrenia have lower and medium perceived social support. Health care providers should screen all schizophrenic patients for their medication adherence on a regular basis.
Background. Insight is the degree of the patient’s awareness and understanding of their attributions, feelings, behavior and disturbing symptoms. Majority of the patients with schizophrenia have poor insight and insight is an important prognostic indicator in schizophrenia to enhance treatment compliances and reducing the risks of clinical deterioration. The main objective of this study was to assess insight and its associated factors among patients with schizophrenia at mental specialized hospital in Ethiopia. Methods. Institutional based cross-sectional study was conducted from May to June 2018 Mental Specialized Hospital among 455 patients with schizophrenia. Insight was measured by an abridged version of Scale to assess unawareness of mental disorder. Positive and Negative Syndrome Scale, Calgary depressive scale, Oslo social support scale was used to identify factors associated with insight. Simple and multiple linear regression analysis were used to assess associated factors of insight in the participants. Results. The mean score of insight was 13.66 (95% CI 13.27, 14.04). Age at first onset of illness, duration of treatments, depressive symptoms were inversely associated with mean insight score; whereas unemployed, positive and negative syndrome, previous hospitalization, >=2 episodes were positively associated with mean insight score. Conclusion. Nearly half of the study participants were scored above the mean insight score so, the clinicians and psychotherapists should have to work together to improve insight among patients with schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.